Trak
Empowering men to take control of their fertility and enhance their sperm quality with a simple, accurate home testing solution.
Empowering men to take control of their fertility and enhance their sperm quality with a simple, accurate home testing solution.
Trak is a Bay Area-based startup that aims to empower men to take control of their fertility and enhance their sperm quality with a simple, accurate home testing solution. Founded in 2012 by Ph.D. scientists who previously worked on medical technologies for national defense at Sandia National Laboratories, the company is focused on developing medical testing instruments and consumables for point-of-care use. Its flagship product, Trak, is a consumer semen analysis platform designed for easy and accurate at-home monitoring of sperm quality.
The startup operates in the Biotechnology, Health Care, and Health and Wellness industries. In May 2019, Trak secured a $2.50M Series A investment from notable investors including J. Hunt Holdings, LabCorp, and Cavendish Impact Capital. With a strong focus on empowering men to manage their fertility and increase the likelihood of conception, Trak presents an innovative approach to at-home health monitoring and has potential in the consumer health market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $2.50M | 3 |
|
06 May 2019 |
| Series A | $5.80M | 5 |
|
16 Jan 2018 |
| Venture Round | Unknown | 1 |
|
21 Dec 2017 |
| Convertible Note | Unknown | 1 |
|
30 Apr 2017 |
| Venture Round | Unknown | 2 |
|
27 May 2016 |
No recent news or press coverage available for Trak.
We care about your data, and we'd love to use cookies make your experience better.
